Thomas James Doyle, SVP, Finance & Accounting at Kura Oncology, Inc. (KURA), sold 2,318 shares at $17.80 ($41K) on 2024-01-29, disclosed to the SEC on 2024-01-31.
Open-market sale of $41k KURA by SVP, Finance & Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.80 | 594 | $11K | 25.6% |
| 2 | $17.80 | 761 | $14K | 32.8% |
| 3 | $17.80 | 963 | $17K | 41.5% |
| Total | $17.80 avg | 2,318 | $41K | 100% |
| Filing → |
| KURA | SELL | 2025-11-14 | $101K | — | Filing → |
| KURA | SELL | 2025-09-29 | $41K | — | Filing → |
| KURA | SELL | 2025-01-28 | $39K | — | Filing → |